We're building the next generation of localized therapeutic platforms to drive musculoskeletal regeneration — with precision, without systemic consequences.
Our platforms are built on the conviction that innovation in biomechanics and transdermal delivery can fundamentally change outcomes for millions of patients — equipping clinicians with tools that are precise, site-directed, and non-systemic by design.
Every device and formulation we create reflects our commitment to clinical excellence, economic efficiency, and most importantly, patient dignity.
We are committed to improving the lives of patients and the practice of medicine by developing and commercializing technologies that improve clinical outcomes, reduce the economic burden of treatment for patients and payers, and leverage insight secured across the patient's journey with our products to equip medical professionals to deliver personalized intervention.
Our product platforms equip clinicians to deliver interventions into targeted anatomical regions and tissue ('Smart, Steered, and Sustained') to optimize the efficacy potential of biomechanical devices, pharmaceuticals and biologics.
The Vector Science & Therapeutics team brings extensive experience in developing and commercializing advanced drug delivery platforms, with deep expertise in transdermal delivery modalities including iontophoresis and sonophoresis. Leveraging our experience, our curiosity, and our strategic partnerships, we ensure access to non-systemic interventions manufactured under the highest cGMP standards.
The three pillars that underpin every solution we develop.
Intelligent, data-informed formulations and devices that adapt to tissue conditions. Our platforms incorporate biofeedback-responsive delivery mechanisms, ensuring therapeutic compounds are released at rates optimized for individual patient physiology — maximizing efficacy while eliminating waste and systemic exposure.
Active transdermal platforms that guide therapeutic compounds with precision to the exact anatomical target. Unlike passive transdermal systems, our steered delivery technology uses physical and biochemical guidance mechanisms to direct therapy to where it's needed most — reducing required dosage and side effects dramatically.
Long-lasting therapeutic effects that support true musculoskeletal tissue regeneration. We move beyond symptom masking to create conditions for genuine healing — sustained release profiles that maintain therapeutic concentrations at the site over clinically meaningful durations, supporting tissue remodeling and functional recovery.